The above cited examples indicate that the specific functions of PVT1 and circPVT1 in hematological malignancies are with some certainty caused by the downstream deregulation of MYC. Interference with PVT1 RNAs would therefore have a direct effect on MYC expression, which makes them potential therapeutic targets. This evidence concerns the gene MYC and hematologic disorder.